Literature DB >> 22040932

Enhanced secretion of TIMP-1 by human hypertrophic scar keratinocytes could contribute to fibrosis.

Franck Simon1, Daniele Bergeron, Sébastien Larochelle, Carlos A Lopez-Vallé, Hervé Genest, Alexis Armour, Véronique J Moulin.   

Abstract

Hypertrophic scars are a pathological process characterized by an excessive deposition of extracellular matrix components. Using a tissue-engineered reconstructed human skin (RHS) method, we previously reported that pathological keratinocytes induce formation of a fibrotic dermal matrix. We further investigated keratinocyte action using conditioned media. Results showed that conditioned media induce a similar action on dermal thickness similar to when an epidermis is present. Using a two-dimensional electrophoresis technique, we then compared conditioned media from normal or hypertrophic scar keratinocytes and determined that TIMP-1 was increased in conditioned media from hypertrophic scar keratinocytes. This differential profile was confirmed using ELISA, assaying TIMP-1 presence on media from monolayer cultured keratinocytes and from RHS. The dermal matrix of these RHS was recreated using mesenchymal cells from three different origins (skin, wound and hypertrophic scar). The effect of increased TIMP-1 levels on dermal fibrosis was also validated independently from the mesenchymal cell origin. Immunodetection of TIMP-1 showed that this protein was increased in the epidermis of hypertrophic scar biopsies. The findings of this study represent an important advance in understanding the role of keratinocytes as a direct potent modulator for matrix degradation and scar tissue remodeling, possibly through inactivation of MMPs. Copyright Â
© 2011 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22040932     DOI: 10.1016/j.burns.2011.09.001

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  16 in total

Review 1.  Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring.

Authors:  Meilang Xue; Christopher J Jackson
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

Review 2.  Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?

Authors:  Michele T Pritchard; Jennifer M McCracken
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

3.  The molecular mechanism of hypertrophic scar.

Authors:  Zhensen Zhu; Jie Ding; Heather A Shankowsky; Edward E Tredget
Journal:  J Cell Commun Signal       Date:  2013-03-18       Impact factor: 5.782

4.  Hyperosmolar Potassium (K+) Treatment Suppresses Osteoarthritic Chondrocyte Catabolic and Inflammatory Protein Production in a 3-Dimensional In Vitro Model.

Authors:  Josh Erndt-Marino; Erik Trinkle; Mariah S Hahn
Journal:  Cartilage       Date:  2017-10-09       Impact factor: 4.634

5.  Investigating the potential of Shikonin as a novel hypertrophic scar treatment.

Authors:  Chen Fan; Yan Xie; Ying Dong; Yonghua Su; Zee Upton
Journal:  J Biomed Sci       Date:  2015-08-16       Impact factor: 8.410

6.  Production of a Self-Aligned Scaffold, Free of Exogenous Material, from Dermal Fibroblasts Using the Self-Assembly Technique.

Authors:  Stéphane Chabaud; Stéphane Bolduc
Journal:  Dermatol Res Pract       Date:  2016-03-09

Review 7.  High-mobility Group Box Protein-1, Matrix Metalloproteinases, and Vitamin D in Keloids and Hypertrophic Scars.

Authors:  Dylan E Lee; Ryan M Trowbridge; Nagi T Ayoub; Devendra K Agrawal
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-07-08

8.  Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9.

Authors:  Joanna Nikitorowicz-Buniak; Xu Shiwen; Christopher P Denton; David Abraham; Richard Stratton
Journal:  J Invest Dermatol       Date:  2014-06-16       Impact factor: 8.551

9.  Shikonin reduces TGF-β1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts.

Authors:  Chen Fan; Ying Dong; Yan Xie; Yonghua Su; Xufang Zhang; David Leavesley; Zee Upton
Journal:  Int J Mol Med       Date:  2015-07-31       Impact factor: 4.101

10.  Origin of Serum Affects Quality of Engineered Tissues Produced by the Self-Assembly Approach.

Authors:  Stéphane Chabaud; Melissa Simard; Isabelle Gendreau; Roxane Pouliot; Stéphane Bolduc
Journal:  Scientifica (Cairo)       Date:  2016-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.